GENEWIZ and Form Bio Launch End-to-End Solution for AAV Gene Therapy Development – Draper Decentralized – 5.20.25
GENEWIZ and Form Bio have partnered to accelerate AAV gene therapy development by integrating long-read sequencing and genome integrity analysis. The collaboration delivers a streamlined workflow that improves vector safety, design, and manufacturability.